Ustekinumab use in Crohn’s disease: a Canadian tertiary care centre experience
Astrid-Jane Greenup(University of British Columbia), Brian Bressler(University of British Columbia), Greg Rosenfeld(British Columbia Centre on Substance Use)
Cited by 51
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis
|Gastroenterology|2007|627
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478